Nishikawa K
Department of Respiratory, National Kagawa Children's Hospital.
Nihon Rinsho. 1996 Nov;54(11):3017-22.
Inhalation of disodium clomoglycate (DSCG) is main therapy for childhood asthma in Japan. Regular inhalation of both DSCG and beta 2 stimulant is recommended for the treatment of severe asthma in the guideline which was made in 1993. Characteristic of childhood asthma such as retardation of growth and exercise-induced asthma is considered as an important view point in Japanese pediatric field. On the other hand inhalation of beclomethasone dipropionate (BDP) is used for the treatment of adult-hood asthma in Japan and WHO global storategy. In the future new treatment will be developed using both DSCG and BDP.
在日本，吸入色甘酸二钠（DSCG）是儿童哮喘的主要治疗方法。1993年制定的指南建议，对于重度哮喘的治疗，应定期吸入DSCG和β2激动剂。儿童哮喘的特征，如生长发育迟缓及运动诱发性哮喘，在日本儿科领域被视为重要观点。另一方面，在日本及世界卫生组织的全球战略中，吸入丙酸倍氯米松（BDP）用于治疗成人哮喘。未来将研发同时使用DSCG和BDP的新疗法。
